von Redaktion LCGC | Okt. 15, 2010
Cytohesins Are Cytoplasmic ErbB Receptor Activators Bill A, Schmitz A, Albertoni B, Song JN, Heukamp LC, Walrafen D, Thorwirth F, Verveer PJ, Zimmer S, Meffert L, Schreiber A, Chatterjee S, Thomas RK, Ullrich RT, Lang T, Famulok M Journal: Cell, Vol 143, No 2, October...
von Redaktion LCGC | Juli 15, 2010
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium Truong T, Hung R J, Amos C I, Wu X, Bickeboller H, Rosenberger A, Sauter W, Illig T, Wichmann H E, Risch A, Dienemann...
von Redaktion LCGC | Juni 15, 2010
Implementing WHO recommendations for palliative care into routine lung cancer therapy: a feasibility project Gaertner J, Wolf J, Scheicht D, Frechen S, Klein U, Hellmich M, Ostgathe C, Hallek M and Voltz R Journal: Journal of palliative medicine, Vol 13, No 6, June...
von Redaktion LCGC | Apr. 15, 2010
Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor Pawar VG, Sos ML, Rode HB, Rabiller M, Heynck S, van Otterlo WA, Thomas RK, Rauh D Journal: Journal of Medicinal Chemistry, Vol 53, No 7, April 2010,...
von Redaktion LCGC | März 15, 2010
Osteoblastic response in patients with non-small cell lung cancer with activating EGFR Mutations and bone metastases during treatment with EGFR kinase inhibitors Ansén S, Bangard C, Querings S, Gabler F, Scheffler M, Seidel D, Saal B, Zander T, Nogová L, Töpelt K,...
